133 related articles for article (PubMed ID: 29502062)
1. [ADS-J1 antagonizes semen-derived enhancer of virus infection-mediated enhancement of transmitted founder HIV-1 and its matched chronic control strain infection].
Liu HM; Ma NN; Luo C; Yuan SY; Liu FL; Yao XG; Zhou CQ; Zou M
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Feb; 38(2):211-216. PubMed ID: 29502062
[TBL] [Abstract][Full Text] [Related]
2. ADS-J1 inhibits semen-derived amyloid fibril formation and blocks fibril-mediated enhancement of HIV-1 infection.
Xun T; Li W; Chen J; Yu F; Xu W; Wang Q; Yu R; Li X; Zhou X; Lu L; Jiang S; Li L; Tan S; Liu S
Antimicrob Agents Chemother; 2015 Sep; 59(9):5123-34. PubMed ID: 26055369
[TBL] [Abstract][Full Text] [Related]
3. ADS-J1 disaggregates semen-derived amyloid fibrils.
Li J; Yang Z; Liu H; Qiu M; Zhang T; Li W; Li Z; Qi T; Qiu Y; Li L; Zhou X; Liu S; Tan S
Biochem J; 2019 Mar; 476(6):1021-1035. PubMed ID: 30877194
[TBL] [Abstract][Full Text] [Related]
4. [PSB0739 inhibits formation of semen-derived amyloid fibril].
Lan Y; Yang Z; Liu H; Cheng H; Liu S; Tan S
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Nov; 38(11):1338-1343. PubMed ID: 30514682
[TBL] [Abstract][Full Text] [Related]
5. Myricetin antagonizes semen-derived enhancer of viral infection (SEVI) formation and influences its infection-enhancing activity.
Ren R; Yin S; Lai B; Ma L; Wen J; Zhang X; Lai F; Liu S; Li L
Retrovirology; 2018 Jul; 15(1):49. PubMed ID: 30012153
[TBL] [Abstract][Full Text] [Related]
6. The anti-parasitic drug suramin potently inhibits formation of seminal amyloid fibrils and their interaction with HIV-1.
Tan S; Li JQ; Cheng H; Li Z; Lan Y; Zhang TT; Yang ZC; Li W; Qi T; Qiu YR; Chen Z; Li L; Liu SW
J Biol Chem; 2019 Sep; 294(37):13740-13754. PubMed ID: 31346035
[TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin Gallate Inhibits Macaque SEVI-Mediated Enhancement of SIV or SHIV Infection.
Zhou RH; Guo L; Liu JB; Liu H; Hou W; Ma TC; Wang X; Wu JG; Ye L; Ho WZ; Li JL
J Acquir Immune Defic Syndr; 2017 Jun; 75(2):232-240. PubMed ID: 28328549
[TBL] [Abstract][Full Text] [Related]
8. [Lactic acid inhibits the formation of semen-derived amyloid fibrils].
Li JQ; Song YL; Xun TR; Tan SY; Liu SW
Nan Fang Yi Ke Da Xue Xue Bao; 2017 Jul; 37(7):907-913. PubMed ID: 28736366
[TBL] [Abstract][Full Text] [Related]
9. SEVI, the semen enhancer of HIV infection along with fragments from its central region, form amyloid fibrils that are toxic to neuronal cells.
Elias AK; Scanlon D; Musgrave IF; Carver JA
Biochim Biophys Acta; 2014 Sep; 1844(9):1591-8. PubMed ID: 24948476
[TBL] [Abstract][Full Text] [Related]
10. ADS-J1 inhibits HIV-1 infection and membrane fusion by targeting the highly conserved pocket in the gp41 NHR-trimer.
Yu F; Lu L; Liu Q; Yu X; Wang L; He E; Zou P; Du L; Sanders RW; Liu S; Jiang S
Biochim Biophys Acta; 2014 May; 1838(5):1296-305. PubMed ID: 24388952
[TBL] [Abstract][Full Text] [Related]
11. [Semen-derived enhancer of viral infection--a key factor in sexual transmission of HIV].
Duan JM; Qiu JY; Tan SY; Liu SW; Li L
Bing Du Xue Bao; 2012 Jan; 28(1):84-8. PubMed ID: 22416356
[TBL] [Abstract][Full Text] [Related]
12. Polyanionic candidate microbicides accelerate the formation of semen-derived amyloid fibrils to enhance HIV-1 infection.
Tan S; Lu L; Li L; Liu J; Oksov Y; Lu H; Jiang S; Liu S
PLoS One; 2013; 8(3):e59777. PubMed ID: 23544097
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the enhancement of infection of human immunodeficiency virus by semen-derived enhancer of virus infection using amyloid-targeting polymeric nanoparticles.
Sheik DA; Brooks L; Frantzen K; Dewhurst S; Yang J
ACS Nano; 2015 Feb; 9(2):1829-1836. PubMed ID: 25619867
[TBL] [Abstract][Full Text] [Related]
14. The anti-HIV activity of ADS-J1 targets the HIV-1 gp120.
Armand-Ugón M; Clotet-Codina I; Tintori C; Manetti F; Clotet B; Botta M; Esté JA
Virology; 2005 Dec; 343(1):141-9. PubMed ID: 16168454
[TBL] [Abstract][Full Text] [Related]
15. No SEVI-mediated enhancement of rectal HIV-1 transmission of HIV-1 in two humanized mouse cohorts.
Van Dis ES; Moore TC; Lavender KJ; Messer RJ; Keppler OT; Verheyen J; Dittmer U; Hasenkrug KJ
Virology; 2016 Jan; 488():88-95. PubMed ID: 26609939
[TBL] [Abstract][Full Text] [Related]
16. The cationic properties of SEVI underlie its ability to enhance human immunodeficiency virus infection.
Roan NR; Münch J; Arhel N; Mothes W; Neidleman J; Kobayashi A; Smith-McCune K; Kirchhoff F; Greene WC
J Virol; 2009 Jan; 83(1):73-80. PubMed ID: 18945786
[TBL] [Abstract][Full Text] [Related]
17. Amyloid-binding small molecules efficiently block SEVI (semen-derived enhancer of virus infection)- and semen-mediated enhancement of HIV-1 infection.
Olsen JS; Brown C; Capule CC; Rubinshtein M; Doran TM; Srivastava RK; Feng C; Nilsson BL; Yang J; Dewhurst S
J Biol Chem; 2010 Nov; 285(46):35488-96. PubMed ID: 20833717
[TBL] [Abstract][Full Text] [Related]
18. ADS-J1 inhibits HIV-1 entry by interacting with gp120 and does not block fusion-active gp41 core formation.
González-Ortega E; Mena MP; Permanyer M; Ballana E; Clotet B; Esté JA
Antimicrob Agents Chemother; 2010 Oct; 54(10):4487-92. PubMed ID: 20643898
[TBL] [Abstract][Full Text] [Related]
19. Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI.
Kim KA; Yolamanova M; Zirafi O; Roan NR; Staendker L; Forssmann WG; Burgener A; Dejucq-Rainsford N; Hahn BH; Shaw GM; Greene WC; Kirchhoff F; Münch J
Retrovirology; 2010 Jun; 7():55. PubMed ID: 20573198
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of HIV-1 infectivity by simple, self-assembling modular peptides.
Easterhoff D; DiMaio JT; Doran TM; Dewhurst S; Nilsson BL
Biophys J; 2011 Mar; 100(5):1325-34. PubMed ID: 21354406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
